According to this, overexpression of MIF has been found in several human neoplasms, including prostate (Wang, Yao, et al., 2019), breast (Avalos‐Navarro et al., 2019), colorectal (Olsson et al., 2020), endometrial (Xiao et al., 2016), hepatocellular (Zhao et al., 2011), and pancreatic ductal cancer cells (Denz et al., 2010), as well as NMSC (Martin et al., 2009). The gene discussed is MIF; the disease is neoplasm.